Technical Articles
Lp(a)
Merck Acquires $2 Billion Licensing Deal from Hengrui: Transforming Lp(a) from "Genetic Destiny" to "Treatable Disorder"
Lp(a), the abbreviated form of lipoprotein(a), represents a distinctive class of plasma lipoprotein. This macromolecular complex consists of apolipoprotein B-100 covalently linked to apolipoprotein(a) via a disulfide bond. While structurally analogous to low-density lipoprotein (LDL), Lp(a) possesses unique pathogenicity conferred by its characteristic multikringle-domain apolipoprotein(a) moiety.
View details
- Cardiovascular
- Lp(a)
- recombinant protein
- 1












